Skip to main content

Mutagenicity and Estrogens

  • Chapter
The Menopause and Postmenopause

Abstract

A number of recent papers suggested that estrogens, including conjugated estrogens, used for the treatment of menopausal symptoms and the prevention of postmenopausal osteoporosis, may cause uterine cancer and breast cancer1–10 On the other hand several investigators found no definite connection of estrogen therapy to uterine cancer or breast cancer11–26 Carcinogenicity of estrogens has been reported previously in experimental animals27–30 The question arises whether estrogens are indeed carcinogenic or mutagenic, and whether they act by altering the hormonal milieu or by increasing susceptibility of the host to other carcinogenic influences. For this reason, it appeared to be of interest to study the direct mutagenic effect of estrogens in bacterial and mammalian systems, including normal and neoplastic human cell lines. We investigated the most commonly used postmenopausal conjugated estrogen preparation: Premarin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. I. Gambrel, R. D. (1977). Estrogens, progestogens and endometrial cancer. J. Reprod. Med., 18, 301

    Google Scholar 

  2. Gray, L. A., Christopherson, W. M. and Hoover, R. N. (1977). Estrogens and endometrial carcinoma. Obstet. Gnecol., 49, 385

    Google Scholar 

  3. Gordon, J., Reagan, J. W., Finkle. W. D and Ziel, H. K. (1977). Estrogen and endometrial carcinoma. N. Engl. J. Med., 297, 570

    Article  PubMed  CAS  Google Scholar 

  4. Hoover, R., Gray, L. A. and Cole, P. (1976). Menopausal estrogens and breast cancer. N. Engl. J. Med., 295, 401

    Article  PubMed  CAS  Google Scholar 

  5. Hoover, R., Fraumeni, J. F., Everson, R. and Myers, M. H. (1976). Cancer of the uterine corpus after hormonal treatment for breast cancer. Lancet, 1, 885

    Article  PubMed  CAS  Google Scholar 

  6. MacMahon, B. (1974). Risk factors for endometrial cancer. Gynecol. Oncol., 2, 122

    Article  PubMed  CAS  Google Scholar 

  7. McDonald, T. W., Annegers, J. F., O’Fallon, W. M., Dockerty, M. B., Malkasian, G. D. and Kurland, L. T. (1977). Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am. J. Obstet. Gnecol., 127, 572

    CAS  Google Scholar 

  8. Siiteri, P. K., Schwartz, B. E. and MacDonald, P. C. (1974). Estrogen receptors and the estrone hypothesis in relation to endometrial and breast cancer. Gnecol. Oncol., 2, 228

    Article  CAS  Google Scholar 

  9. Smith, D. C., Prentice, R., Thompson, D. J. and Hermann, W. L. (1975). Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med., 293, 1 164

    Google Scholar 

  10. Ziel, H. K. and Finkle, W. D. (1975). Increased risk of endometrial carcinoma among users of conjugated estrogen. N. Engl. J. Med., 293, 1167

    Article  PubMed  CAS  Google Scholar 

  11. Cooke, L D. (1976). Estrogens as a cause of endometrial carcinoma. Br. Med. J., I, 1209

    Article  Google Scholar 

  12. Dunn, L. J. and Brandbury, J. T. (1967). Endocrine factors in endometrial carcinoma: a preliminary report. Arn. J. Obstet. Gnecol., 97, 465

    CAS  Google Scholar 

  13. Gordan, G. S. and Greenberg, B. G. (1976). Exogenous estrogens and endometrial cancer. Possgracl. Med., 59, 66

    CAS  Google Scholar 

  14. Greenblatt, R. B. (1976). Oestrogens and endometrial cancer. In R. J. Beard (ed.). The Menopause, pp. 247–263. ( Lancaster: MTP Press )

    Google Scholar 

  15. Horwitz, R. I. and Feinstein, A. R. (1977). New methods of sampling and analysis to remove bias in case-control research: no association found for estrogens and endometrial cancer. Proc. Am. Soc. Clin. Invest.

    Google Scholar 

  16. Lauritzen, C. (1976). Estrogens and Corpus uteri carcinoma. Serualmediin, 5, 624

    Google Scholar 

  17. Malkasian, G. D., McDonald, T. W. and Pratt, J. H. (1977). Carcinoma of the endometrium. Mayo Clinic experience. Mayo Clin. Proc., 52, 175

    PubMed  Google Scholar 

  18. Studd, J. W. W. (1976). Oestrogens as a cause of endometrial carcinoma. Br. Med. J., 1, 1144

    Google Scholar 

  19. Brezina, K., Janisch, H. and Muller-Tyl, E. (1973). Das Mammogramm unter Kontrazeptiva. Wien Klin. Wochenschr., 85, 785

    PubMed  CAS  Google Scholar 

  20. Burch, J. C., Byrd, B. F. and Vaughn, W. K. (1975). Effects of long-term estrogen administration to women following hysterectomy. Front. Hormone Res., 3, 208

    CAS  Google Scholar 

  21. Drill, V. A. (1975). Oral contraceptives: relations to mammary cancer, benign breast lesions, and cervical cancer. Ann. Rev. Pharmacol., 15, 367

    Article  PubMed  CAS  Google Scholar 

  22. Fechner, R. E. (1970). Breast cancer during oral contraceptive therapy. Cancer, 26, 1204

    Article  PubMed  CAS  Google Scholar 

  23. Gordan, G. S., Picchi, J. and Roof, B. S. (1973). Antifracture efficacy of long-term estrogens for osteoporosis. Trans. Assoc. Am. Physicians, 86, 326

    PubMed  CAS  Google Scholar 

  24. Henneman, P. H. and Wallach, S. (1957). A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis. Arch. Intern. Med.. 100, 715

    Article  CAS  Google Scholar 

  25. Ostergaard, E. (1969). Oral anticonception: side effects and risks. Acta Obstet. Gynecol., (Suppl. 1 ), 48, 57

    Google Scholar 

  26. Wallach, S. and Henneman, P. H. (1959). Prolonged estrogen therapy in postmenopausal women. J. Am. Med. Assoc., 171, 1637

    Article  Google Scholar 

  27. Cook, J. W. and Dodds, E. C. (1933). Sex hormones and cancer-producing compounds. Nature, 131, 205

    Article  CAS  Google Scholar 

  28. Gardner, W. U. (1944). Tumors in experimental animals receiving steroid hormones. Surgery, 16, 8

    CAS  Google Scholar 

  29. Meissner, W. A., Sommers, S. C. and Sherman, G. (1957). Endometrial hyperplasia, endometrial carcinoma, and endometriosis produced experimentally by estrogen. Cancer, 10, 500

    Article  PubMed  CAS  Google Scholar 

  30. Perry, I. H. and Ginzton, L. L. (1937). The development of tumors in female mice treated with 1:2:5:6-dibenzanthracene and Theclin. Am. J. Cancer, 29, 680

    CAS  Google Scholar 

  31. Ames, B. N., McCann, J. and Yamasaki, E. (1975). Methods for detecting carcinogens and mutagens with the Salmonella mammalian-microsome mutagenicity test. Mutat. Res., 31, 347

    PubMed  CAS  Google Scholar 

  32. Banerjee, A., Jung, O. and Huang, C. C. (1977). Response of hematopoietic cell lines derived from patients with Down’s Syndrome and from normal individuals to mitomycin C and caffeine. J. Natl. Cancer Inst., 59, 37

    PubMed  CAS  Google Scholar 

  33. Furukawa, M. and Huang, C. C. (1978). Sister chromatid exchanges induced by cyclophosphamide in V97 cells cultured in diffusion chambers in mice. Mutat. Res., 57, 233

    Article  PubMed  CAS  Google Scholar 

  34. Huang, C. C., Babbitt, H. and Ambrus, J. L. (1969). Chromosomes and DNA synthesis in the stumptailed monkey (Macaca speciosa), with special regard to marker and sex chromosomes. Folio Primat., 11, 28

    Article  CAS  Google Scholar 

  35. Huang, C. C., Banerjee, A., Tan, J. C. and Hou, Y. (1977). Comparison of radiosensitivity between human hematopoietic cell lines derived from patients with Down’s Syndrome and from normal persons. J. Natl. Cancer Inst., 59, 33

    PubMed  CAS  Google Scholar 

  36. Huang, C. C. and Furukwa, M. (1978). Sister chromatid exchanges in human lymphoid cell lines cultured in diffusion chambers in mice. Exp. Cell Res., 111, 458

    Article  PubMed  CAS  Google Scholar 

  37. McCann, J., Choi, E., Yamasaki, E. and Ames, B. N. (1975). Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA, 72, 5135

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1980 MTP Press Limited

About this chapter

Cite this chapter

Ambrus, J.L. et al. (1980). Mutagenicity and Estrogens. In: Pasetto, N., Paoletti, R., Ambrus, J.L. (eds) The Menopause and Postmenopause. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-7230-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-7230-1_22

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-011-7232-5

  • Online ISBN: 978-94-011-7230-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics